What We Think

The Clinical Case for Differentiating Marijuana and Opioid Use

During a press conference on Feb. 23, White House Press Secretary Sean Spicer made comments that some may interpret to link recreational marijuana usage and the opioid crisis that has swept across the United States in recent years. The same press conference issued language that made distinctions between the two, which led to confusion in…

The Yin and Yang of 2016: A Crisis Year Holds Promise

Despite being a peak year in the nationwide opioid epidemic, 2016 was also a year of forward-moving changes in both policy and perception of opioid use. In his latest blog, Dr. Steven Bentsen—Beacon’s Associate Chief Medical Officer who oversees substance use services—weighs in on 2016 as a turning point for substance use treatment, and how…

How Beacon is Combating the Opioid Addiction Crisis

2 million Americans are addicted to prescription opioids Opioid overdose is now the #1 cause of accidental death in America Opioid-related deaths have increased 200% since 2000 Nearly 80% of people with opioid addiction do not receive treatment Wait lists for treatment can be a year long Beacon’s Clinical Philosophy Opioid addiction is a chronic…

Confronting the Crisis of Opioid Addiction

Beacon takes the view that opioid addiction is a chronic brain disease that is best treated by a chronic disease model of care. Read Beacon’s blog post on the subject and download our white paper, “Confronting the Crisis of Opioid Addiction”.

Legislation

February 2016 was a good month for making progress against opioid addiction. Not only did the White House ask for an additional $1.1 billion to fight opioid abuse, but the Senate Judiciary Committee passed the bipartisan Comprehensive Addiction and Recovery Act.